David P. Tietjen

Internal Medicine

2780 Bob Wallace Ave SW
Huntsville, AL 35805

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 4 publications

Correction to: Tenapanor as Therapy for Hyperphosphatemia in Maintenance Dialysis Patients: Results from the OPTIMIZE Study.

Correction to: Tenapanor as Therapy for Hyperphosphatemia in Maintenance Dialysis Patients: Results from the OPTIMIZE Study.

Journal: Kidney360

Published: April 17, 2026

The Positive Impact of Patient Education on Tenapanor Adherence in the OPTIMIZE Study.

The Positive Impact of Patient Education on Tenapanor Adherence in the OPTIMIZE Study.

Journal: Nephrology nursing journal : journal of the American Nephrology Nurses' Association

Published: July 07, 2025

Tenapanor as Therapy for Hyperphosphatemia in Maintenance Dialysis Patients: Results from the OPTIMIZE Study.

Tenapanor as Therapy for Hyperphosphatemia in Maintenance Dialysis Patients: Results from the OPTIMIZE Study.

Journal: Kidney360

Published: July 07, 2023

Tenapanor Improves Long-Term Control of Hyperphosphatemia in Patients Receiving Maintenance Dialysis: the NORMALIZE Study.

Tenapanor Improves Long-Term Control of Hyperphosphatemia in Patients Receiving Maintenance Dialysis: the NORMALIZE Study.

Journal: Kidney360

Published: June 01, 2023

Showing 1-4 of 4

Last Updated: 09/26/2026